Inogen and Abiomed Are Struggling in 2019

Inogen (NASDAQ: INGN) and Abiomed (NASDAQ: ABMD) are innovative medical device companies that have put up impressive growth numbers in recent years. However, they both failed to meet Wall Street's expectations for their second-quarter earnings results and cut full-year guidance in response.

In this segment from Industry Focus: Healthcare, host Shannon Jones and Fool.com contributor Brian Feroldi dig into these businesses' quarterly numbers and discuss whether they can get their growth engines back on track.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. A full transcript follows the video.

Source Fool.com